Does RESLIZUMAB Cause Asthma? 82 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Asthma have been filed in association with RESLIZUMAB (CINQAIR). This represents 13.2% of all adverse event reports for RESLIZUMAB.
82
Reports of Asthma with RESLIZUMAB
13.2%
of all RESLIZUMAB reports
1
Deaths
27
Hospitalizations
How Dangerous Is Asthma From RESLIZUMAB?
Of the 82 reports, 1 (1.2%) resulted in death, 27 (32.9%) required hospitalization, and 1 (1.2%) were considered life-threatening.
Is Asthma Listed in the Official Label?
Yes, Asthma is listed as a known adverse reaction in the official FDA drug label for RESLIZUMAB.
What Other Side Effects Does RESLIZUMAB Cause?
Dyspnoea (86)
Drug ineffective (80)
Incorrect dose administered (63)
Hypertension (47)
Headache (41)
Wheezing (40)
Cough (36)
Oropharyngeal pain (31)
Fatigue (29)
Myalgia (29)
What Other Drugs Cause Asthma?
ALBUTEROL (18,997)
DUPILUMAB (12,312)
MEPOLIZUMAB (11,033)
BUDESONIDE\FORMOTEROL (10,045)
PREDNISONE (10,028)
OMALIZUMAB (9,354)
MONTELUKAST (8,372)
FLUTICASONE\SALMETEROL (7,985)
TIOTROPIUM (7,944)
BUDESONIDE (4,544)
Which RESLIZUMAB Alternatives Have Lower Asthma Risk?
RESLIZUMAB vs RESMETIROM
RESLIZUMAB vs RESTASIS
RESLIZUMAB vs RETINOL
RESLIZUMAB vs REVATIO
RESLIZUMAB vs REVEFENACIN